ZIVO Insider Trading Activity and SEC Form 4 Filings
ZIVO insider trading summary
Over the past 12 months, insiders at Zivo Bioscience, Inc. (ZIVO) reported 10 open-market purchases worth $881K by 7 insiders and no sales on SEC Form 4. Net insider buying was $881K.
Latest ZIVO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Laith L Yaldoo | Insider | Buy | $15K (1,543 @ $9.72) |
| Feb 12, 2026 | Mark E Strome | 10% Owner | Buy | $195K (20,000 @ $9.77) |
| Feb 12, 2026 | Strome Group, Inc. | Insider | Buy | $195K (20,000 @ $9.77) |
| Feb 12, 2026 | Strome Investment Management LP | Insider | Buy | $195K (20,000 @ $9.77) |
| Feb 10, 2026 | Laith L Yaldoo | Insider | Buy | $25K (2,434 @ $10.27) |
| Jan 26, 2026 | John Bernard Payne | President and CEO | Buy | $100K (11,709 @ $8.54) |
| Jan 26, 2026 | Alison A Cornell | Insider | Buy | $100K (11,709 @ $8.54) |
| Jan 14, 2026 | Laith L Yaldoo | Insider | Buy | $15K (1,766 @ $8.49) |
| Jan 14, 2026 | Christopher D. Maggiore | Insider | Buy | $15K (1,766 @ $8.49) |
| Nov 28, 2025 | Laith L Yaldoo | Director | Buy | $25K (2,777 @ $9.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.